Follicular lymphoma trials in United States
102 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 375
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07029217 - Phase 2Taking peopleObinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- Where
- Valhalla
- Age
- 3 years to 31 years
- People
- 25
- Run by
- New York Medical College
See details and how to joinNCT02393157 - Phase 3Taking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Albany, Anchorage, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Baton Rouge, Bethesda, Blue Ash, Boston, Brooklyn, Charlotte, Chesterfield, Cincinnati, Clovis, Columbia, Columbus, Des Moines, Detroit, Eugene, Evanston, Fairfax, Fort Wayne, Hackensack, Huntsville, Iowa City, Jacksonville, Lexington, Los Alamitos, Louisville, Lubbock, Macon, Madison, Milwaukee, Mineola, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New York, Peoria, Phoenix, Pittsburgh, Portland, Richmond, Rochester, Saint Paul, Salt Lake City, San Diego, Santa Monica, Shenandoah, Springfield, Tacoma, Tyler, Wilmington, Winston-Salem, Ypsilanti
- Age
- 18 years to 130 years
- People
- 1,018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - Phase 2Taking peopleGolcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
- Where
- Albert Lea, Eau Claire, Jacksonville, La Crosse, Mankato, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 41
- Run by
- Mayo Clinic
See details and how to joinNCT06834373 - Phase 1Not yet taking people in United StatesAxatilimab + CAR-T for High-Risk Lymphoma
- Where
- Atlanta
- Age
- 8 years and over
- People
- 29
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT07638982 - Phase 1Taking peopleA Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Where
- Anaheim, Austin, Boston, Dallas, Duarte, Fairfax, Fairway, Hackensack, Irving, Kansas City, Louisville, Myrtle Beach, Nashville, Newton, Norwalk, Oklahoma City, Omaha, Overland Park, Port Angeles, Poulsbo, Rockville, San Antonio, Seattle, Tucson, Westwood
- Age
- 18 years and over
- People
- 453 worldwide
- Run by
- Pfizer
See details and how to joinNCT03460977 · EU 2023-509179-18-00 - Phase 2Taking peopleTesting Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Where
- Albuquerque, Atlanta, Baltimore, Baton Rouge, Battle Creek, Boiling Springs, Boise, Burlington, Charleston, Charlotte, Chicago, Cleveland, Clinton Township, Concord, Costa Mesa, Danville, Dearborn, Detroit, Durham, Easley, Fargo, Farmington Hills, Fayetteville, Fruitland, Gainesville, Grand Rapids, Greenville, Greer, Iowa City, Irvine, Jackson, Kalamazoo, Kansas City, Laguna Hills, Lebanon, Little Rock, Louisville, Madison, Maywood, Memphis, Meridian, Milwaukee, Muskegon, Nampa, Newberg, New Berlin, New York, Niles, Norton Shores, Novi, Oklahoma City, Orange, Oregon City, Overland Park, Philadelphia, Portland, Reed City, Richmond, Rochester, Rogers, Saint Johnsbury, Saint Joseph, San Francisco, Seattle, Seneca, Southfield, Springdale, Traverse City, Tucson, Twin Falls, Webster, West Bloomfield, Westwood, Wilkes-Barre, Winston-Salem, Wyandotte, Wyoming
- Age
- 18 years and over
- People
- 396
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT05633615 - Phase 1Taking peopleA Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Where
- East Brunswick, Grand Rapids, Houston, Jacksonville, Los Angeles
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT07424833 - Phase 2Taking peopleTafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma
- Where
- Seattle
- Age
- 18 years and over
- People
- 30
- Run by
- University of Washington
See details and how to joinNCT07731789 - Phase 2Not yet taking people in United StatesPrizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell Therapy
- Where
- Gilbert, La Jolla
- Age
- 18 years and over
- People
- 55
- Run by
- AbelZeta Inc.
See details and how to joinNCT07875413 - Phase 2Taking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Austin, Charlotte, Chicago, Columbus, Duarte, Houston, Iowa City, Jacksonville, Milwaukee, Nashville, New Brunswick, New York, Overland Park, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, St Louis, Tampa, Waukee
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - Phase 1Taking peopleCD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Where
- Boston
- Age
- 18 years and over
- People
- 24
- Run by
- Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06026319 - No phaseTaking peopleA Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Where
- Bethesda, Charlotte, Cincinnati, Columbus, Fargo, Iowa City, Maumee, Reno, Rochester, Sioux Falls, St Louis, York
- Age
- 0 years and over
- People
- 550
- Run by
- Tempus AI
See details and how to joinNCT07154823 - Phase 2Taking peopleLoncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Where
- Duarte
- Age
- 18 years and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT05672251 - Phase 2Taking peopleEmapalumab Prevention of CAR-T Cell Associated Toxicities
- Where
- Boston
- Age
- 18 years and over
- People
- 28
- Run by
- Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06550141 - Phase 1Taking peoplePhase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Where
- Ann Arbor, Aurora, Chicago, Detroit, Duarte, Houston, Los Angeles, New York, Pittsburgh, Scottsdale
- Age
- 18 years and over
- People
- 46
- Run by
- SciTech Development, Inc.
See details and how to joinNCT04234048 - Phase 1/2Taking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Augusta, Baton Rouge, Bethesda, Birmingham, Boston, Buffalo, Chattanooga, Detroit, Fort Collins, Houston, Iowa City, Jacksonville, La Jolla, Las Vegas, Louisville, Miami, Nashville, Newnan, New York, Palo Alto, Phoenix, Richmond, Rochester, Santa Monica, Scottsdale, Seattle, Tampa, Tucson, Zion
- Age
- 18 years and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - Phase 1/2Taking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Boston, Charlotte, Hackensack, Houston, La Jolla, New York, Rochester, Seattle, Winston-Salem
- Age
- 18 years and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - Phase 2Taking peopleRituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Where
- Tampa
- Age
- 18 years and over
- People
- 43
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06350318 - Phase 2Taking peopleEpco, Zanu, Ritux for R/R FL or MZL
- Where
- Boston, Columbus, New York
- Age
- 18 years and over
- People
- 71
- Run by
- Reid Merryman, MD
See details and how to joinNCT06563596 - No phaseTaking peopleVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Where
- Portland
- Age
- 18 years and over
- People
- 45
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06784167 - Phase 2Taking peopleMosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
- Where
- Duarte, Irvine
- Age
- 18 years and over
- People
- 41
- Run by
- City of Hope Medical Center
See details and how to joinNCT06453044 - Phase 1Taking peoplehuCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 6
- Run by
- University of Pennsylvania
See details and how to joinNCT07343934 - Phase 1Enrolling by invitationCD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Where
- Baltimore
- Age
- 18 years and over
- People
- 15
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07168486 - Phase 1Taking peopleRituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Where
- Cleveland
- Age
- 18 years and over
- People
- 15
- Run by
- Paolo Caimi, MD
See details and how to joinNCT07225439